Jefferies Downgrades HMS Holdings (HMSY) to Hold; Valuation Full Amid Improved Outlook
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Jefferies downgrade HMS Holdings (Nasdaq: HMSY) from Buy to Hold, but lifts its price target from $19 to $23 upon revisit of valuation metrics.
Analyst David Windley commented today,
HMSY's traction among health plans, including with its novel prepay clinical review product, has buoyed Commercial growth and investor sentiment. However, we believe 20% Commercial growth and successful NJ reprocurement already are discounted in the stock, as evidenced by the +90% YTD move and premium NTM P/E valuation (vs. 3- and 5-yr historic averages). HMSY has topped our PT making risk/reward on near-term events unfavorable.
On key contracts:
Consensus expectations seem to already reflect retention of NJ, and we include $28M in 2017 revenue. HMS continues to wait for guidance from NJ on protest and/or reprocurement. Failing to secure NJ is a $2-3 risk to the stock. On Medicare RAC, HMS has submitted bids for multiple regions; awards could be made by year-end. Lower ADR limits and unattractive payment terms mean the economics of the new contracts will be (far) less attractive than the prior program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Raises Price Target on Broadcom Ltd. (AVGO) to $210 Following 4Q
- Oppenheimer Raises Price Target on CarMax (KMX) to $72 Ahead of 3Q
- Jefferies Cuts Price Target on GTx, Inc. (GTXI) to $7 Following Enobosarm Trial Results
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Downgrades
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!